Assessing the efficacy of nano- and micro-sized magnetic particles as contrast agents for MRI cell tracking

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Taylor, Arthur ^a   Herrmann, Anne ^a   Moss, Diana ^a   Sée, Violaine ^a   Davies, Karen ^b   Williams, Steve R ^b   Murray, Patricia ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BANGS BEADS; FERATRACK; MOLDAY ION EVERGREEN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG; CONTRAST MEDIUM; IRON; MAGNETITE NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TRACKING; CELLULAR DISTRIBUTION; CHICK EMBRYO; COLLOID; CONTROLLED STUDY; DRUG EFFICACY; DRUG UPTAKE; EMBRYO; FLUORESCENCE IMAGING; IN VIVO STUDY; INTERNALIZATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; ANIMAL; CELL LINE; CONFOCAL MICROSCOPY; CYTOLOGY; ELECTRON MICROSCOPY; INTRACELLULAR SPACE; MESENCHYMAL STROMA CELL; METABOLISM; PHENOTYPE; PROCEDURES; STAINING; ULTRASTRUCTURE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL TRACKING; CONTRAST MEDIA; INTRACELLULAR SPACE; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MESENCHYMAL STROMAL CELLS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; PHENOTYPE; STAINING AND LABELING;

EID: 84903550341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100259     Document Type: Article

References (36)

1. Taylor A,Wilson KM, Murray P, Fernig DG, Levy R (2012) Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet? Chem Soc Rev 41: 2707-2717.
2. Kircher MF, Gambhir SS, Grimm J (2011) Noninvasive cell-tracking methods. Nat Rev Clin Oncol 8: 677-688.
3. Brader P, Serganova I, Blasberg RG (2013) Noninvasive Molecular Imaging Using Reporter Genes. J Nucl Med 54: 167-172.
4. de Vries IJM, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotech 23: 1407-1413. (Pubitemid 41679393)
5. Richards JMJ, Shaw CA, Lang NN, Williams MC, Semple SIK, et al. (2012) In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans. Circ Cardiovascular Imaging 5: 509-517.
6. Toso C, Vallee JP, Morel P, Ris F, Demuylder-Mischler S, et al. (2008) Clinical Magnetic Resonance Imaging of Pancreatic Islet Grafts After Iron Nanoparticle Labeling. Am J Transplant 8: 701-706. (Pubitemid 351287550)
7. Zhu J, Zhou L, XingWu F (2006) Tracking Neural Stem Cells in Patients with Brain Trauma. New Engl J Med 355: 2376-2378. (Pubitemid 44837805)
8. Kalva SP, Blake MA, Sahani DV (2006) MR Contrast Agents. Applied Radiology 35: 18-27. (Pubitemid 43137251)
9. Bulte JWM (2009) In Vivo MRI Cell Tracking: Clinical Studies. Am J Roentgenol 193: 314-325.
10. Sun C, Lee JSH, Zhang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliver Rev 60: 1252-1265.
11. Fish WW (1988) Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. In: James F. Riordan BLV, editor. Method Enzymol: Academic Press. pp. 357-364.
12. Skotland T, Sontum PC, Oulie I (2002) In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. J Pharmaceut Biomed 28: 323-329. (Pubitemid 34266911)
13. Jung CW, Jacobs P (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13: 661-674.
14. Shapiro E, Koretsky A (2008) Micron-Sized Iron Oxide Particles (MPIOs) for Cellular Imaging: More Bang for the Buck. In: Bulte JM, Modo MJ, editors. Nanoparticles in Biomedical Imaging: Springer New York. pp. 141-161.
15. Ren G, Chen X, Dong F, Li W, Ren X, et al. (2012) Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues. Stem Cells Transl Med 1: 51-58.
16. Monopoli MP, Aberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nano 7: 779-786.
17. Albanese A, Tang PS, Chan WCW (2012) The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems. Annu Rev Biomed Eng 14: 1-16.
18. Cengelli F, Maysinger D, Tschudi-Monnet F, Montet X, Corot C, et al. (2006) Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures. J Pharmacol Exp Ther 318: 108-116.
19. Rezwan K, Studart AR, Vörös J, Gauckler LJ (2005) Change of ζ Potential of Biocompatible Colloidal Oxide Particles upon Adsorption of Bovine Serum Albumin and Lysozyme. J Phys Chem B 109: 14469-14474. (Pubitemid 41161741)
20. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, et al. (2003) Clinically Applicable Labeling of Mammalian and Stem Cells by Combining Superparamagnetic Iron Oxides and Transfection Agents. Radiology 228: 480-487. (Pubitemid 36910091)
21. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, et al. (2005) Cell Tagging with Clinically Approved Iron Oxides: Feasibility and Effect of Lipofection, Particle Size, and Surface Coating on Labeling Efficiency1. Radiology 235: 155-161. (Pubitemid 40432249)
22. Shapiro EM, Skrtic S, Koretsky AP (2005) Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 53: 329-338. (Pubitemid 40171047)
23. Laurent S, Burtea C, Thirifays C, Häfeli UO, Mahmoudi M (2012) Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and "Cell Vision". PLoS ONE 7: e29997.
24. Michael L, Florence L, Valentin-Adrian M, Marie-Geneviève B, François G, et al. (2010) Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties. Nanotechnology 21: 395103.
25. Soenen SJH, Himmelreich U, Nuytten N, Pisanic TR, Ferrari A, et al. (2010) Intracellular Nanoparticle Coating Stability Determines Nanoparticle Diagnostics Efficacy and Cell Functionality. Small 6: 2136-2145.
26. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, et al. (2004) MRI detection of single particles for cellular imaging. PNAS 101: 10901-10906. (Pubitemid 38989558)
27. Grainger DW (2009) Nanotoxicity assessment: all small talk? Adv Drug Deliver Rev 61: 419-421.
28. Geraldes CFGC, Laurent S (2009) Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol I 4: 1-23.
29. Carroll MRJ, Woodward RC, House MJ, Teoh WY, Amal R, et al. (2010) Experimental validation of proton transverse relaxivity models for superparamagnetic nanoparticle MRI contrast agents. Nanotechnology. 21.
30. Laurent S, Forge D, Port M, Roch A, Robic C, et al. (2008) Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications. Chemical Reviews 108: 2064-2110.
31. Lévy M, Wilhelm C, Devaud M, Levitz P, Gazeau F (2012) How cellular processing of superparamagnetic nanoparticles affects their magnetic behavior and NMR relaxivity. Contrast Media & Molecular Imaging 7: 373-383.
32. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, et al. (2003) Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging. Magn Reson Med 49: 646-654. (Pubitemid 36389974)
33. Simon G, Bauer J, Saborovski O, Fu Y, Corot C, et al. (2006) T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol 16: 738-745. (Pubitemid 44149388)
34. Klug G, Kampf T, Bloemer S, Bremicker J, Ziener CH, et al. (2010) Intracellular and extracellular T1 and T2 relaxivities of magneto-optical nanoparticles at experimental high fields. Magn Reson Med 64: 1607-1615.
35. Rashidi H, Sottile V (2009) The chick embryo: hatching a model for contemporary biomedical research. BioEssays 31: 459-465.
36. Boss A, Oppitz M, Wehrl HF, Rossi C, Feuerstein M, et al. (2008) Measurement of T1, T2, and magnetization transfer properties during embryonic development at 7 Tesla using the chicken model. J Magn Reson Im 28: 1510-1514.